ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Clinical trials for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat head and neck cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs, vorinostat and azacitidine, given together to adults with nasopharyngeal cancer or nasal NK-T cell lymphoma that has come back or spread. The goal is to find a dose that kills more cancer cells while limiting sid…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:22 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC